Life Sciences
Top stories summarized by our editors
7/16/2019

Twitter is rolling out a desktop redesign globally with a new home screen layout, simplified navigation, easy profile changing, advanced search capabilities and theme and color personalization options. Since earlier this year, Twitter has been testing the changes and took user feedback into consideration when deciding on the final desktop version.

More Summaries:
Twitter
7/16/2019

The Washington Post is launching Zeus Insights, a first-party data ad tool that features detailed contextual targeting and user-intent predictions supported by its audience insights and machine learning. The Washington Post intends to license the platform to publishers globally by integrating it with its Arc technology, which reaches 600 million unique users, to help them compete with ad services offered by Facebook and Google and to rely less on cookie-related data.

More Summaries:
Facebook, Google
7/16/2019

The US Patent and Trademark Office has approved a fourth patent for a cancer combo therapy filed by Provectus, of which Pfizer is a co-assignee. The approved application was for the use of intratumoral PV-10 and combined with systemic immunomodulatory therapy to treat a class of solid tumor cancers.

Full Story:
Seeking Alpha
7/16/2019

Publicis' HealthFront scheduled for New York this week will focus on branded content, technology and social influencers for the 400 attendees invited by the company. The event is similar to traditional television Upfronts, where new television shows are announced, and the NewFronts held for digital media ventures.

Full Story:
FiercePharma
More Summaries:
Publicis
7/16/2019

The FDA has issued two innovation challenges to the medical device sterilization industry: one to identify alternatives to ethylene oxide sterilization and the other to find ways to reduce EO emissions. AdvaMed chief lobbyist Greg Crist noted the medical device industry has already been seeking alternatives to EO sterilization, which is used for more than half of medical devices.

More Summaries:
FDA, Greg Crist, AdvaMed
7/16/2019

NanoString Technologies and the MODEL-AD consortium agreed to work together to advance the research and development of two nCounter gene expression panels to be used in Alzheimer's disease studies. The panels measure the expression of 770 genes covering 30 modules recently discovered in a human brain tissue study.

Full Story:
Seeking Alpha
7/16/2019

SIJ Surgical, which focuses on sacroiliac joint fusion solutions, has been acquired by Osseus Fusion Systems. The acquisition includes SIJ's Blue Topaz CompresSIve Sacroiliac Screw System, which is designed to reduce the radiographic signature and improve osseointegration.

Full Story:
Becker's Spine Review
7/16/2019

Cancer Genetics' biopharma services business has been acquired by Interpace Diagnostics for about $23.5 million. The business had net revenues of about $15 million last year.

More Summaries:
Interpace Diagnostics, Interpace
7/16/2019

A new pact will expand distribution of Oncimmune's EarlyCDT Lung cancer assay in Spain after one of its distribution partners signed a sales and marketing deal with Vithas Group. The test is designed to diagnose all forms of lung cancer at any stage by measuring levels of seven autoantibodies.

More Summaries:
Spain, Oncimmune, Vithas Group
7/16/2019

Abbott has obtained approval from the FDA for the fourth generation of its MitraClip valve repair device for the treatment of mitral regurgitation. The new product, called MitraClip G4, offers an expanded number of clip sizes and an upgraded catheter.

Full Story:
MassDevice (Boston)
More Summaries:
Abbott, FDA